Relationship Enhancement Better sexual function and increased desire can have positive effects on intimate relationships and overall connection with your partner
Personalized Guidance: Genetic Testing and Contraceptive Metabolism The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
2025 milestone: Combined Mounjaro and Zepbound sales of $36.5 billion made tirzepatide the worlds best-selling drug in 2025 surpassing Novo Nordisks combined semaglutide portfolio ($33 billion) and Mercks Keytruda ($31.7 billion)
Stiffer arteries and pre-existing vascular blockages mean older bodies are far more susceptible to sudden changes in blood pressure
June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss